ArticleScientific reports2023

Inhibition of Drp1 orchestrates the responsiveness of breast cancer cells to paclitaxel but insignificantly relieves paclitaxel-related ovarian damage in mice.

Adel I Alalawy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.